>
 Kedia Advisory received NCDEX Commodity Award in 2023 for Best Research House, MCX Leading Research in 2022, NCDEX Commodity Award in 2022 for BEST RESEARCH, NCDEX's Krishi Awards 2021: Outstanding Research House Contribution, MCX Award for “Best Broking House – Research in 2019”, Business Excellence Award by Zee Business, 2016          Kedia Advisory received NCDEX Commodity Award for 2022 for BEST RESEARCH, NCDEX's Krishi Awards 2021: Outstanding Research House Contribution & Kedia Advisory Received MCX Award for “Best Broking House – Research in 2019”          Kedia Advisory received NCDEX's Krishi Awards 2021: Outstanding Research House Contribution & Kedia Advisory Received MCX Award for “Best Broking House – Research” On 26th April 2019          Kedia Advisory received NCDEX's Krishi Awards 2021: OUTSTANDING RESEARCH HOUSE CONTRIBUTION          Kedia Advisory Received MCX Award for “Best Broking House – Research” On 26th April 2019.
Kedia Advisory
Kedia Advisory Received MCX Award for “Best Broking House – Research” On 26th April 2019.

take a look at our
Details

Trading Call

*INTRADAY*: BUY AUROPHARMA FEB ABV 411.5 TGT 415. SL BELOW 408 CMP: 411.40. NSE

  • Timeframe :INTRA_DAY
  • Script :AUROPHARMA
  • Complex :EQFUTURE
  • Entry :411.5000
  • Target 1 :415.0000
  • Call Type :TECHNICAL
  • Segment :NSE
  • Action :BUY
  • StopLoss :408.0000
  • Target 2:0.0000
  • Date :06 Feb 2023 10:10AM
  • Update Date :
  • Comment : *INTRADAY*: ONCE EXIT LONG IN AUROPHARMA FEB AT 415.00. BOOK PROFIT RS. 3,500.00. NSE